These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33892178)

  • 21. Mechanosensitive Ca
    Morrell AE; Robinson ST; Silva MJ; Guo XE
    Connect Tissue Res; 2020; 61(3-4):389-398. PubMed ID: 31931640
    [No Abstract]   [Full Text] [Related]  

  • 22. Negative Association Between Sclerostin and INSL3 in Isolated Human Osteocytes and in Klinefelter Syndrome: New Hints for Testis-Bone Crosstalk.
    Di Nisio A; De Toni L; Rocca MS; Ghezzi M; Selice R; Taglialavoro G; Ferlin A; Foresta C
    J Clin Endocrinol Metab; 2018 May; 103(5):2033-2041. PubMed ID: 29452406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bromodomain Inhibitor
    Siegenthaler B; Ghayor C; Gjoksi-Cosandey B; Ruangsawasdi N; Weber FE
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide contributes to rapid sclerostin protein loss following mechanical load.
    Buck HV; Torre OM; Leser JM; Gould NR; Ward CW; Stains JP
    Biochem Biophys Res Commun; 2024 Oct; 727():150315. PubMed ID: 38950493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
    Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
    Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.
    Roforth MM; Fujita K; McGregor UI; Kirmani S; McCready LK; Peterson JM; Drake MT; Monroe DG; Khosla S
    Bone; 2014 Feb; 59():1-6. PubMed ID: 24184314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
    Li F; Cain JD; Tombran-Tink J; Niyibizi C
    J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
    Poole KE; van Bezooijen RL; Loveridge N; Hamersma H; Papapoulos SE; Löwik CW; Reeve J
    FASEB J; 2005 Nov; 19(13):1842-4. PubMed ID: 16123173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia.
    Achiou Z; Toumi H; Touvier J; Boudenot A; Uzbekov R; Ominsky MS; Pallu S; Lespessailles E
    Bone; 2015 Dec; 81():691-701. PubMed ID: 26409255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover.
    Metzger CE; Narayanan A; Zawieja DC; Bloomfield SA
    J Bone Miner Res; 2017 Apr; 32(4):802-813. PubMed ID: 27796050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARG in osteocytes controls cell bioenergetics and systemic energy metabolism independently of sclerostin levels in circulation.
    Baroi S; Czernik PJ; Khan MP; Letson J; Crowe E; Chougule A; Griffin PR; Rosen CJ; Lecka-Czernik B
    Mol Metab; 2024 Oct; 88():102000. PubMed ID: 39074536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.
    Maycas M; McAndrews KA; Sato AY; Pellegrini GG; Brown DM; Allen MR; Plotkin LI; Gortazar AR; Esbrit P; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):486-497. PubMed ID: 27683064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
    Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
    Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin.
    Knowles HJ; Chanalaris A; Koutsikouni A; Cribbs AP; Grover LM; Hulley PA
    Front Endocrinol (Lausanne); 2023; 14():1167734. PubMed ID: 37223031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice.
    Liu W; Wang Z; Yang J; Wang Y; Li K; Huang B; Yan B; Wang T; Li M; Zou Z; Yang J; Xiao G; Cui ZK; Liu A; Bai X
    Open Biol; 2019 May; 9(5):180262. PubMed ID: 31088250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.
    Leupin O; Piters E; Halleux C; Hu S; Kramer I; Morvan F; Bouwmeester T; Schirle M; Bueno-Lozano M; Fuentes FJ; Itin PH; Boudin E; de Freitas F; Jennes K; Brannetti B; Charara N; Ebersbach H; Geisse S; Lu CX; Bauer A; Van Hul W; Kneissel M
    J Biol Chem; 2011 Jun; 286(22):19489-500. PubMed ID: 21471202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: A critical assessment of the mechanism of action.
    Bhattacharyya S; Pal S; Chattopadhyay N
    Eur J Pharmacol; 2018 May; 826():39-47. PubMed ID: 29476877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
    Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
    J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes.
    Gooi JH; Pompolo S; Karsdal MA; Kulkarni NH; Kalajzic I; McAhren SH; Han B; Onyia JE; Ho PW; Gillespie MT; Walsh NC; Chia LY; Quinn JM; Martin TJ; Sims NA
    Bone; 2010 Jun; 46(6):1486-97. PubMed ID: 20188226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.